Hamilton Thorne (CVE:HTL) Shares Up 4.3% – Here’s What Happened

Hamilton Thorne Ltd. (CVE:HTL) traded up 4.3% during mid-day trading on Tuesday . The stock traded as high as C$1.45 and last traded at C$1.45. 25,700 shares were traded during mid-day trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Up 4.3%

The firm has a market cap of C$149.69 million, a price-to-earnings ratio of 58.94 and a beta of 0.54. The stock has a 50-day moving average of C$1.45 and a 200-day moving average of C$1.45. The company has a current ratio of 3.20, a quick ratio of 2.25 and a debt-to-equity ratio of 16.60.

Hamilton Thorne Company Profile

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.